A breeding programme at the University of Ghana leveraging genetic diversity and EMS-induced mutagenesis to develop nicosulfuron-resistant parental maize lines, enabling cost-effective weed control and scalable hybrid seed production for Ghanaian farmers.
Weeds cause substantial yield losses in maize production across Ghana. While nicosulfuron-based herbicides offer an affordable and effective weed control solution, many improved hybrid maize varieties and their parental lines are highly susceptible to this herbicide, resulting in yield losses exceeding 85%. This sensitivity creates a significant barrier to the adoption of improved hybrids and inflates seed production costs due to reliance on manual weeding.
This project addresses the challenge by exploiting genetic diversity and inducing new mutations for nicosulfuron resistance using ethyl methanesulfonate (EMS) mutagenesis. The goal is to develop resilient parental lines that can be reconstituted into high-performing hybrids, enabling breeders and seed producers to scale up operations economically while supporting farmers' access to improved, herbicide-tolerant maize seed.
Approach and methodology:
Key benefits for partners:
The project is at an early-to-mid stage of development. Sensitivity testing of parental lines has been completed, establishing the baseline susceptibility profile. The next steps involve setting up mutagenesis experiments, generating M2 mutant populations, and evaluating their reaction to nicosulfuron. Identified resistant mutants will be used to reconstitute hybrids, with parallel efforts to map quantitative trait loci associated with resistance. The programme is positioned to deliver validated parental lines and molecular tools that can be integrated into commercial hybrid seed production pipelines.
The University of Ghana is a comprehensive public research university in Accra, combining broad academic breadth with a strong applied research mission. Industry interfaces through the Institute of Applied Science and Technology, which convenes engagement programs and facilitates contract work, internships, and demonstrations. Clinical translation is enabled by the on‑campus University of Ghana Medical Centre and the Noguchi Memorial Institute for Medical Research, providing advanced laboratories and patient‑adjacent research. Research is supported by competitive Ghanaian government sources and international funders. A dedicated technology transfer and IP unit within the Office of Research, Innovation and Development supports protection, licensing, and industry collaboration agreements.